| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 272 | 48 | 12 | 356 | | Cost of Revenue |
-
|
-
|
-
| (7,101) | | | Gross Profit | 272 | 48 | 12 | 7,457 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,336 | 2,069 | 2,062 | 10,815 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 13 | (23) | 49 | 14 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,243) | (1,998) | (2,099) | (3,372) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,945 | 2,421 | 1,148 | (9,809) | | Earnings Before Interest And Taxes | (296) | 421 | (951) | (13,214) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (296) | 421 | (951) | (13,214) | | Income Tax Expense |
-
| 2 | 0 | 34 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (296) | 421 | (951) | (13,214) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (296) | 421 | (951) | (13,214) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($296) | $421 | ($951) | ($13,214) |
|
0.01% Nasdaq 0.00%
Income Statement
